These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 11035059

  • 1. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.
    Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y.
    J Immunol; 2000 Oct 15; 165(8):4254-63. PubMed ID: 11035059
    [Abstract] [Full Text] [Related]

  • 2. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 15; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 3. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T.
    J Bone Miner Metab; 2000 Aug 15; 18(4):177-84. PubMed ID: 10874596
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct 15; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 5. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.
    Karst M, Gorny G, Galvin RJ, Oursler MJ.
    J Cell Physiol; 2004 Jul 15; 200(1):99-106. PubMed ID: 15137062
    [Abstract] [Full Text] [Related]

  • 6. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 15; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 7. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.
    J Bone Miner Res; 2002 Jul 15; 17(7):1200-10. PubMed ID: 12096833
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M, Kukita A, Kukita T, Ogata Y, Hotokebuchi T, Kohashi O.
    Bone; 2001 May 15; 28(5):474-83. PubMed ID: 11344046
    [Abstract] [Full Text] [Related]

  • 9. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 15; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaissé JM, Foged NT.
    J Biol Chem; 2003 Nov 07; 278(45):44975-87. PubMed ID: 12933809
    [Abstract] [Full Text] [Related]

  • 11. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.
    Bone; 1999 Nov 07; 25(5):517-23. PubMed ID: 10574571
    [Abstract] [Full Text] [Related]

  • 12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep 07; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 13. The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro.
    Fox SW, Haque SJ, Lovibond AC, Chambers TJ.
    J Immunol; 2003 Apr 01; 170(7):3679-87. PubMed ID: 12646633
    [Abstract] [Full Text] [Related]

  • 14. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N.
    Endocrinology; 2001 Aug 01; 142(8):3656-62. PubMed ID: 11459815
    [Abstract] [Full Text] [Related]

  • 15. Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones.
    Woo KM, Choi Y, Ko SH, Ko JS, Oh KO, Kim KK.
    Exp Mol Med; 2002 Nov 30; 34(5):347-52. PubMed ID: 12526098
    [Abstract] [Full Text] [Related]

  • 16. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM, Mangashetti LS, Yogesha SD, Wani MR.
    J Immunol; 2003 Jul 01; 171(1):142-51. PubMed ID: 12816992
    [Abstract] [Full Text] [Related]

  • 17. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
    Sugatani T, Alvarez UM, Hruska KA.
    J Cell Biochem; 2003 Sep 01; 90(1):59-67. PubMed ID: 12938156
    [Abstract] [Full Text] [Related]

  • 18. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H.
    J Immunol; 2003 Nov 15; 171(10):5130-9. PubMed ID: 14607912
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N, Kitaura H, Yoshida N, Nakayama K.
    Bone; 2003 Oct 15; 33(4):721-32. PubMed ID: 14555278
    [Abstract] [Full Text] [Related]

  • 20. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells.
    Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ, Kim HM, Kwon BS.
    Eur J Immunol; 2001 Jul 15; 31(7):2179-88. PubMed ID: 11449372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.